• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

hsa-miR-9-5p 介导的 TSPAN9 下调与肝细胞癌不良预后和肿瘤免疫浸润呈正相关。

hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration.

机构信息

Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, 410078 Hunan, China.

Department of Epidemiology and Health Statistics, Guilin Medical University, Guilin, 541004 Guangxi, China.

出版信息

J Immunol Res. 2022 May 12;2022:9051229. doi: 10.1155/2022/9051229. eCollection 2022.

DOI:10.1155/2022/9051229
PMID:35600044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9119760/
Abstract

Tetraspanins (TSPANs) play crucial roles in cell adhesion, migration, and metastasis of human cancer. However, there is no study in revealing the aspects of TSPAN9 traits and its functions in hepatocellular carcinoma (HCC) prognosis. Our study is the first to portray the TSPAN9 expression in HCC tissues with immunohistochemistry (IHC) analysis. Subsequently, a series of bioinformatics analyses such as expression estimation, survival assessment, and correlation analysis were implemented to dig out the possible upstream noncoding RNAs (ncRNAs) for TSPAN9 in HCC. In this way, the relevance within TSPAN9 and tumor immunity was then explored. We found that the TSPAN9 was downregulated in HCC tissues and had a correlation with HCC prognosis. Furthermore, we identified that the AL139383.1-hsa-miR-9-5p axis was the upstream ncRNA-related pathway most associated with TSPAN9 in HCC. Besides that, expression of TSPAN9 held a significantly negative correlation with tumor immunocyte infiltration as well as immune checkpoint CTLA4. TSPAN9-related immunomodulators were mainly enriched in T cell activation, leukocyte cell-cell adhesion, regulation of T cell activation, and regulation of leukocyte cell-cell adhesion signaling pathway. In conclusion, our results indicated that hsa-miR-9-5p-mediated downregulation of TSPAN9 was associated with poor HCC prognosis, immune-related signaling pathway, and tumor immune infiltration.

摘要

四跨膜蛋白(Tetraspanins,TSPANs)在人类癌症的细胞黏附、迁移和转移中发挥着关键作用。然而,目前尚无研究揭示 TSPAN9 特征及其在肝细胞癌(HCC)预后中的功能。我们的研究首次通过免疫组织化学(IHC)分析描绘了 HCC 组织中 TSPAN9 的表达。随后,我们进行了一系列生物信息学分析,如表达估计、生存评估和相关性分析,以挖掘 HCC 中 TSPAN9 的可能上游非编码 RNA(ncRNA)。通过这种方式,我们进一步探讨了 TSPAN9 与肿瘤免疫之间的相关性。我们发现 TSPAN9 在 HCC 组织中下调,并且与 HCC 预后相关。此外,我们确定了 AL139383.1-hsa-miR-9-5p 轴是与 HCC 中 TSPAN9 最相关的上游 ncRNA 相关途径。此外,TSPAN9 的表达与肿瘤免疫细胞浸润以及免疫检查点 CTLA4 呈显著负相关。TSPAN9 相关免疫调节剂主要富集在 T 细胞激活、白细胞细胞间黏附、T 细胞激活调节以及白细胞细胞间黏附信号通路调节中。总之,我们的研究结果表明,hsa-miR-9-5p 介导的 TSPAN9 下调与 HCC 不良预后、免疫相关信号通路和肿瘤免疫浸润有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/9d3a75446a98/JIR2022-9051229.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/ccae0bcaee07/JIR2022-9051229.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/318336b34ddf/JIR2022-9051229.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/b7efc4f672da/JIR2022-9051229.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/9d3a75446a98/JIR2022-9051229.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/ccae0bcaee07/JIR2022-9051229.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/318336b34ddf/JIR2022-9051229.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/b7efc4f672da/JIR2022-9051229.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f247/9119760/9d3a75446a98/JIR2022-9051229.004.jpg

相似文献

1
hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration.hsa-miR-9-5p 介导的 TSPAN9 下调与肝细胞癌不良预后和肿瘤免疫浸润呈正相关。
J Immunol Res. 2022 May 12;2022:9051229. doi: 10.1155/2022/9051229. eCollection 2022.
2
Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.miR-362-3p/miR-425-5p 下调 ZC3H13 的表达与肝癌患者预后不良及不良结局相关。
Aging (Albany NY). 2022 Mar 12;14(5):2304-2319. doi: 10.18632/aging.203939.
3
ncRNA-mediated SOX4 overexpression correlates with unfavorable outcomes and immune infiltration in hepatocellular carcinoma.ncRNA 介导的 SOX4 过表达与肝细胞癌不良预后和免疫浸润相关。
BMC Gastroenterol. 2024 Aug 14;24(1):265. doi: 10.1186/s12876-024-03346-0.
4
CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.环状 RNA hsa_circ_0110102 通过 miR-580-5p/PPARα/CCL2 通路抑制巨噬细胞激活和肝癌进展。
Aging (Albany NY). 2021 Apr 23;13(8):11969-11987. doi: 10.18632/aging.202900.
5
LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.长链非编码 RNA MAGI2-AS3 通过靶向 miR-374b-5p/SMG1 信号通路抑制肝癌细胞增殖和迁移。
J Cell Physiol. 2019 Aug;234(10):18825-18836. doi: 10.1002/jcp.28521. Epub 2019 Mar 28.
6
LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.长链非编码 RNA CARMN 通过调控 miR-192-5p/LOXL2 轴影响肝细胞癌预后。
Oxid Med Cell Longev. 2022 Oct 8;2022:9277360. doi: 10.1155/2022/9277360. eCollection 2022.
7
Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.环状 RNA 动力蛋白 1(DYNC1H1)下调通过 miR-140-5p 抑制肝细胞癌增殖和迁移。
J Cell Physiol. 2019 Aug;234(10):17775-17785. doi: 10.1002/jcp.28403. Epub 2019 Mar 12.
8
CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.环状 CCNA1 沉默作为 miR-106b-5p 的海绵吸附物抑制 GPM6A 表达,通过增强 DYNC1I1 表达和激活 AKT/ERK 信号通路促进 HCC 进展。
Int J Biol Sci. 2022 Jan 1;18(2):637-651. doi: 10.7150/ijbs.66915. eCollection 2022.
9
NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p.NEAT1 通过海绵吸附 hsa-mir-139-5p 上调 TGF-β1 诱导肝细胞癌进展。
J Cell Physiol. 2018 Nov;233(11):8578-8587. doi: 10.1002/jcp.26524. Epub 2018 May 24.
10
Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.敲低末端分化诱导非编码 RNA(TINCR)通过靶向 miR-218-5p/DEAD-box 解旋酶 5(DDX5)轴抑制肝癌细胞的增殖和侵袭。
J Cell Physiol. 2020 Oct;235(10):6990-7002. doi: 10.1002/jcp.29595. Epub 2020 Jan 29.

引用本文的文献

1
TSPAN9 inhibits malignant progression of hepatocellular carcinoma.四跨膜蛋白9抑制肝细胞癌的恶性进展。
Transl Cancer Res. 2025 Jul 30;14(7):4046-4057. doi: 10.21037/tcr-2025-174. Epub 2025 Jul 18.
2
Identification of pyroptosis-associated miRNAs in the immunoscape and prognosis of hepatocellular carcinoma.肝细胞癌免疫景观及预后中焦亡相关 microRNA 的鉴定
BMC Cancer. 2024 Dec 18;24(1):1513. doi: 10.1186/s12885-024-13276-5.
3
An overview on the interaction between non-coding RNAs and CTLA-4 gene in human diseases.非编码 RNA 与 CTLA-4 基因在人类疾病中的相互作用概述。

本文引用的文献

1
Expression and clinical significance of CMTM1 in hepatocellular carcinoma.CMTM1在肝细胞癌中的表达及临床意义
Open Med (Wars). 2021 Jan 28;16(1):217-223. doi: 10.1515/med-2021-0221. eCollection 2021.
2
miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.miR-9-5p 通过靶向 ESR1 促进肝癌细胞的增殖、迁移和侵袭。
Mol Cell Biochem. 2021 Feb;476(2):575-583. doi: 10.1007/s11010-020-03927-z. Epub 2020 Oct 27.
3
Cancer burden of major cancers in China: A need for sustainable actions.
Med Oncol. 2024 Nov 25;42(1):13. doi: 10.1007/s12032-024-02552-w.
4
Tspan protein family: focusing on the occurrence, progression, and treatment of cancer.四跨膜蛋白家族:聚焦于癌症的发生、发展及治疗
Cell Death Discov. 2024 Apr 22;10(1):187. doi: 10.1038/s41420-024-01961-0.
5
The role of Tetraspanins in digestive system tumor development: update and emerging evidence.四跨膜蛋白在消化系统肿瘤发生发展中的作用:最新进展与新证据
Front Cell Dev Biol. 2024 Feb 8;12:1343894. doi: 10.3389/fcell.2024.1343894. eCollection 2024.
6
Migrasomes and tetraspanins in hepatocellular carcinoma: current status and future prospects.肝细胞癌中的迁移小体和四跨膜蛋白:现状与未来展望
Future Sci OA. 2023 Aug 8;9(9):FSO890. doi: 10.2144/fsoa-2023-0086. eCollection 2023 Oct.
7
An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.一种用于预测肝细胞癌免疫治疗疗效和预后的免疫相关生物标志物指数。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10319-10333. doi: 10.1007/s00432-023-04899-5. Epub 2023 Jun 5.
8
miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells.miR-9 和 miR-181a 通过靶向 Gab2 抑制肝癌 HepG2 细胞的增殖和迁移。
Genes (Basel). 2022 Nov 18;13(11):2152. doi: 10.3390/genes13112152.
中国主要癌症的癌症负担:需要采取可持续行动。
Cancer Commun (Lond). 2020 May;40(5):205-210. doi: 10.1002/cac2.12025. Epub 2020 May 2.
4
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.与慢性丙型肝炎病毒感染相关的肝细胞癌机制及直接抗病毒治疗的影响
J Hepatocell Carcinoma. 2020 Apr 15;7:45-76. doi: 10.2147/JHC.S221187. eCollection 2020.
5
Tetraspanins.四跨膜蛋白
Curr Biol. 2020 Mar 9;30(5):R204-R206. doi: 10.1016/j.cub.2020.01.007.
6
Adoptive T-cell therapy for HBV-associated HCC and HBV infection.用于乙肝相关肝癌和乙肝感染的过继性T细胞疗法。
Antiviral Res. 2020 Apr;176:104748. doi: 10.1016/j.antiviral.2020.104748. Epub 2020 Feb 19.
7
lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.长链非编码 RNA MEG3 通过海绵吸附 miR-9-5p 来上调 SOX11 抑制肝癌细胞的生长。
Braz J Med Biol Res. 2019;52(10):e8631. doi: 10.1590/1414-431X20198631. Epub 2019 Sep 16.
8
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
9
TSPAN9 and EMILIN1 synergistically inhibit the migration and invasion of gastric cancer cells by increasing TSPAN9 expression.TSPAN9 和 EMILIN1 通过增加 TSPAN9 的表达协同抑制胃癌细胞的迁移和侵袭。
BMC Cancer. 2019 Jun 26;19(1):630. doi: 10.1186/s12885-019-5810-2.
10
TISIDB: an integrated repository portal for tumor-immune system interactions.TISIDB:一个用于肿瘤-免疫系统相互作用的综合知识库门户。
Bioinformatics. 2019 Oct 15;35(20):4200-4202. doi: 10.1093/bioinformatics/btz210.